
- Telehealth Visits
- Insurance plan information

Jessi Humphreys, MD
- Telehealth Visits
- Insurance plan information



Jessi Humphreys, MD
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Jessi Humphreys is a palliative care physician, working with seriously ill patients in the hospital.
In her research endeavors, Humphreys investigates resiliency and wellness, medical education, and palliative care in underserved populations, including global palliative care.
Humphreys earned her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine and a fellowship in hospice and palliative medicine at UCSF.
Humphreys is a member of the American Academy of Hospice and Palliative Medicine.
Education & training
Board certification
- Hospice & Palliative Medicine, American Board of IM/Hospice & Palliative Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Palliative Medicine, UCSF Graduate Medical Education
Residency
- Internal Medicine, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, Stanford University School of Medicine
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.